Display options
Share it on

Indian J Psychiatry. 2006 Jul;48(3):149-53. doi: 10.4103/0019-5545.31577.

Regional brain metabolism in schizophrenia: An FDG-PET study.

Indian journal of psychiatry

R Seethalakshmi, S R Parkar, N Nair, S A Adarkar, A G Pandit, S A Batra, N S Baghel, S H Moghe

Affiliations

  1. Research Associate, Department of Psychiatry, K.E.M. Hospital, Mumbai.

PMID: 20844644 PMCID: PMC2932984 DOI: 10.4103/0019-5545.31577

Abstract

BACKGROUND: Recent technological advances have established beyond any doubt the biological nature of schizophrenia. Functional neuroimaging using FDG-PET forms an important technique in understanding the biological underpinnings of psychopathology of schizophrenia.

METHODS: Eighteen male patients diagnosed as having schizophrenia and having active psychosis as determined by PANSS were subjected to FDG-PET scanning under resting conditions. The glucose uptake in selected regions of interest was studied across the spectrum of schizophrenia.

RESULTS: Chronicity and severity of illness did not influence cerebral glucose metabolism. Participants with negative schizophrenia had significantly decreased metabolism in all regions of the brain as compared to the positive type. The positive syndrome of schizophrenia was associated with significantly increased glucose metabolism in the medial temporal regions, basal ganglia and left thalamic regions. Hypometabolism was also noted in the cerebellum.

CONCLUSION: While a number of brain areas can be identified as potential causative regions and hypotheses regarding putative mechanisms can be formed, the considerable heterogeneity of schizophrenia poses a great challenge in the precise delineation of the disease process.

Keywords: Brain metabolism; FDG-PET; schizophrenia

References

  1. Arch Gen Psychiatry. 1982 Oct;39(10):1121-4 - PubMed
  2. Trends Cogn Sci. 2001 Apr 1;5(4):135-136 - PubMed
  3. Am J Psychiatry. 2003 Jan;160(1):128-33 - PubMed
  4. Arch Gen Psychiatry. 1992 Jul;49(7):522-30 - PubMed
  5. Arch Gen Psychiatry. 1983 Mar;40(3):258-63 - PubMed
  6. Schizophr Bull. 1987;13(2):261-76 - PubMed
  7. Arch Gen Psychiatry. 1987 Feb;44(2):119-25 - PubMed
  8. Am J Psychiatry. 1999 Aug;156(8):1190-9 - PubMed
  9. Trends Neurosci. 2000 Sep;23(9):412-7 - PubMed
  10. Eur Arch Psychiatry Clin Neurosci. 2005 Oct;255(5):308-12 - PubMed
  11. Schizophr Bull. 1999;25(1):7-9 - PubMed
  12. Am J Psychiatry. 2002 Feb;159(2):227-37 - PubMed
  13. Br J Psychiatry. 1995 May;166(5):563-82 - PubMed
  14. Arch Gen Psychiatry. 1987 Feb;44(2):126-9 - PubMed
  15. J Neurol Neurosurg Psychiatry. 1990 Sep;53(9):725-6 - PubMed
  16. Arch Gen Psychiatry. 1988 Jun;45(6):523-32 - PubMed
  17. Lancet. 1974 Dec 21;2(7895):1484-6 - PubMed
  18. Schizophr Bull. 1998;24(2):203-18 - PubMed
  19. Arch Gen Psychiatry. 1982 Mar;39(3):251-9 - PubMed
  20. Psychol Med. 2000 May;30(3):491-504 - PubMed
  21. Arch Gen Psychiatry. 2000 Nov;57(11):1033-8 - PubMed
  22. Schizophr Bull. 1997;23(3):423-35 - PubMed

Publication Types